{"id":"dhea","rwe":[],"_fda":{"id":"8c95390f-f204-41d4-a7c8-22a37a5a04ef","set_id":"123f5269-45eb-4dcd-be66-76c6665b8d13","openfda":{"nui":["N0000175838","M0009540","M0017672","N0000175601","N0000175824","N0000000146","M0001109"],"unii":["2334LJD2E9","GO1N1ZPR3B","4964P6T9RB","C24W7J5D5R","97C5T2UQ7J","883WKN7W8X","7L3E358N9L","2DI9HA706A","076WHW89TW","459AG36T1B","4G7DS2Q64Y","S7YTV04R8O","3XMK78S47O"],"route":["ORAL"],"spl_id":["8c95390f-f204-41d4-a7c8-22a37a5a04ef"],"brand_name":["Hormone Harmony"],"spl_set_id":["123f5269-45eb-4dcd-be66-76c6665b8d13"],"package_ndc":["70558-0008-1"],"product_ndc":["70558-0008"],"generic_name":["ACETALDEHYDE, DOPAMINE HYDROCHLORIDE, DHEA (DEHYDROEPIANDROSTERONE), 7-OXO- DEHYDROEPIANDROSTERONE 3-ACETATE, FOLLICULINUM, OOPHORINUM (SUIS), CHOLESTERINUM, PROGESTERONE, TESTOSTERONE, CORTISONE ACETICUM, ALDOSTERONE, ANDROSTERONE, FOLLICLE STIMULATING HORMONE"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Gonadotropins [CS]","Progesterone [CS]","Androstanes [CS]"],"substance_name":["7-KETO-DEHYDROEPIANDROSTERONE","ACETALDEHYDE","ALDOSTERONE","ANDROSTERONE","CHOLESTEROL","CORTISONE ACETATE","DOPAMINE HYDROCHLORIDE","ESTRONE","FOLLITROPIN","PRASTERONE","PROGESTERONE","SUS SCROFA OVARY","TESTOSTERONE"],"pharm_class_epc":["Gonadotropin [EPC]","Progesterone [EPC]","Androgen [EPC]"],"pharm_class_moa":["Androgen Receptor Agonists [MoA]"],"manufacturer_name":["Pro Weight Loss Inc."],"is_original_packager":[true]},"purpose":["HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration."],"version":"3","warnings":["WARNINGS: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a healthcare professional before use. Tamper seal: sealed for your protection. Do not use if seal is broken or missing."],"questions":["QUESTIONS: Dist. by Pro Weight Loss Inc., 94 Boylston Cir. Shrewsbury, MA 01545 • 508-842-4600"],"effective_time":"20240122","active_ingredient":["ACTIVE INGREDIENTS: Acetaldehyde 6X, 12X, 30X, 200X, Dopamine Hydrochloride 6X, 12X, 30X, 200X, DHEA (Dehydroepiandrosterone) 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, 7-Oxo-Dehydroepiandrosterone 3β-Acetate, 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Folliculinum 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Oophorinum (Suis) 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Cholesterinum 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Progesterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Testosterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Cortisone Aceticum 12X, 30X, 200X, 12C, 30C, 60C, 200C, Aldosterone 12C, 30C, 60C, 200C, Androsterone 12C, 30C, 60C, 200C, Follicle Stimulating Hormone 12C, 30C, 60C, 200C."],"inactive_ingredient":["INACTIVE INGREDIENTS: demineralized water, 25% ethanol"],"indications_and_usage":["HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration."],"dosage_and_administration":["DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by your health professional. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Hormone Harmony Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo- Dehydroepiandrosterone 3-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone ACETALDEHYDE ACETALDEHYDE DOPAMINE HYDROCHLORIDE DOPAMINE PRASTERONE PRASTERONE 7-KETO-DEHYDROEPIANDROSTERONE 7-KETO-DEHYDROEPIANDROSTERONE ESTRONE ESTRONE SUS SCROFA OVARY SUS SCROFA OVARY CHOLESTEROL CHOLESTEROL PROGESTERONE PROGESTERONE TESTOSTERONE TESTOSTERONE CORTISONE ACETATE CORTISONE ALDOSTERONE ALDOSTERONE ANDROSTERONE ANDROSTERONE FOLLITROPIN FOLLITROPIN WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: NDC 70558-0008-1 Pro Weight Loss HOMEOPATHIC Hormone Harmony 1 FL OZ (30 ml) Hormone Harmony"]},"tags":[{"label":"Gonadotropin [EPC]","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"hormone imbalances","category":"indication"},{"label":"low energy","category":"indication"},{"label":"inability to handle stress","category":"indication"},{"label":"trouble focusing","category":"indication"},{"label":"changes in mood","category":"indication"},{"label":"infertility","category":"indication"},{"label":"Pro Weight Loss Inc.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"176 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"147 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"142 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"113 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"98 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"94 reports"},{"date":"","signal":"INSOMNIA","source":"FDA FAERS","actionTaken":"86 reports"},{"date":"","signal":"FEELING ABNORMAL","source":"FDA FAERS","actionTaken":"83 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"81 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"81 reports"}]},"trials":[],"aliases":["dehydroepiandrosterone","Prasterone, Dehydroepiandrosterone","Dehydroepiandrosterone","dehydroepiandrosterone; prasterone","Prasterone, Dehydroepiandrosterone, Vaginorm"],"company":"Pro Weight Loss Inc.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DHEA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:03:37.466315+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:03:42.904248+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DHEA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:03:43.390046+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:03:36.197207+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:03:36.197239+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:03:53.622783+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:03:36.197246+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:03:45.334065+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1875999/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:03:44.140529+00:00"}},"allNames":"hormone harmony","offLabel":[],"synonyms":["Hormone Harmony","7-KETO-DEHYDROEPIANDROSTERONE"],"timeline":[],"approvals":[],"brandName":"Hormone Harmony","ecosystem":[],"mechanism":{"moaClass":"Androgen Receptor Agonists [MoA]","modality":"Small Molecule","drugClass":"Gonadotropin [EPC]","explanation":"","oneSentence":"","technicalDetail":"DHEA is a precursor to androstenedione, which is then converted to testosterone and estrogen through a series of enzyme-catalyzed reactions, ultimately influencing the hypothalamic-pituitary-gonadal axis."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"DHEA\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=dhea","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dhea","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:33:48.117530","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:03:53.866543+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"dhea","indications":{"approved":[{"id":"dhea-hormone-imbalance-symptoms","name":"Hormone imbalance symptoms","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Men and women","pivotalTrial":null,"restrictions":[],"patientPopulation":"Men and women","diagnosticRequired":null,"brandNameForIndication":"Hormone Harmony"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":["Chronic Low Back Pain"],"enrollment":108,"completionDate":"2029-12-31"},{"nctId":"NCT07451145","phase":"NA","title":"Stress Reduction Program for Iraqi Medical Students","status":"COMPLETED","sponsor":"University of Thi-Qar","startDate":"2024-10-01","conditions":["Psychological Stress","Academic Stress"],"enrollment":135,"completionDate":"2025-01-01"},{"nctId":"NCT07443605","phase":"NA","title":"Allostatic Load Assessment Using Hair Cortisol and Dehydroepiandrosterone Sulfate Concentration in Patients Affected by Periodontal Disease","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2021-09-01","conditions":["Stress Disorders"],"enrollment":42,"completionDate":"2024-12-31"},{"nctId":"NCT07179952","phase":"PHASE2","title":"Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2027-01-01","conditions":["Asthma"],"enrollment":30,"completionDate":"2028-09-30"},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":["Mild Cognitive Impairment","Dementia, Mild"],"enrollment":73,"completionDate":"2026-02-09"},{"nctId":"NCT07407647","phase":"PHASE2","title":"Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-01","conditions":["Anal Carcinoma","Cervical Carcinoma","Malignant Female Reproductive System Neoplasm","Rectal Carcinoma","Vaginal Carcinoma","Vulvar Carcinoma"],"enrollment":25,"completionDate":"2026-12-31"},{"nctId":"NCT04488757","phase":"NA","title":"Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-11-04","conditions":["Chronic Widespread Pain","Stress, Psychological","Stress, Physiological"],"enrollment":70,"completionDate":"2026-08-31"},{"nctId":"NCT07320040","phase":"","title":"Evaluation of Emotion-related Salivary Molecular Biomarkers","status":"RECRUITING","sponsor":"Sys2Diag","startDate":"2022-11-14","conditions":["Emotion"],"enrollment":240,"completionDate":"2027-06-14"},{"nctId":"NCT07353515","phase":"","title":"Peri-Implant Sulcus Fluid Stress Markers in Health and Disease","status":"COMPLETED","sponsor":"Inonu University","startDate":"2023-02-15","conditions":["Peri-implantitis","Peri-implant Mucositis","Peri-Implant Health"],"enrollment":62,"completionDate":"2024-06-15"},{"nctId":"NCT07323329","phase":"PHASE2,PHASE3","title":"Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-10-10","conditions":["Infertility","Infertility (IVF Patients)"],"enrollment":165,"completionDate":"2026-11-12"},{"nctId":"NCT03648385","phase":"PHASE2","title":"Effects of DHEA in Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-01-09","conditions":["Pulmonary Arterial Hypertension"],"enrollment":26,"completionDate":"2024-12-30"},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":["Type 1 Diabetes Mellitus"],"enrollment":60,"completionDate":"2026-12-15"},{"nctId":"NCT07158125","phase":"","title":"Pathogenesis of Periodontal Disease in Individuals With Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-09-15","conditions":["Psoriasis"],"enrollment":60,"completionDate":"2026-04-06"},{"nctId":"NCT07116317","phase":"","title":"Salivary Stress Markers Associated With Malocclusion Severity","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-08-11","conditions":["Malocclusion"],"enrollment":120,"completionDate":"2026-02-09"},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":["Long Covid-19"],"enrollment":100,"completionDate":"2027-01-27"},{"nctId":"NCT05562518","phase":"PHASE4","title":"GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-03-21","conditions":["Vulvovaginal Atrophy","Breast Cancer"],"enrollment":160,"completionDate":"2027-12-31"},{"nctId":"NCT05623059","phase":"PHASE1,PHASE2","title":"Evaluate Pharmacokinetics and Safety of Slow Release DHEA","status":"COMPLETED","sponsor":"Indiana University","startDate":"2023-03-03","conditions":["Asthma","Genotype"],"enrollment":18,"completionDate":"2025-04-24"},{"nctId":"NCT06472765","phase":"","title":"Vaginal Ecosystem and Network in the United States Study","status":"ENROLLING_BY_INVITATION","sponsor":"Vaginal Biome Science","startDate":"2024-05-16","conditions":["Bacterial Vaginosis","Candidiasis","Urinary Tract Infections","Genitourinary Syndrome of Menopause","Lichen Sclerosus","Lichen Planus","Vulvodynia","Endometriosis","Ureaplasma Infections","Cancer","Desquamative Inflammatory Vaginitis"],"enrollment":3250,"completionDate":"2028-05-15"},{"nctId":"NCT06852560","phase":"NA","title":"A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2025-05","conditions":["Breast Cancer"],"enrollment":0,"completionDate":"2026-11"},{"nctId":"NCT02357472","phase":"NA","title":"The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2014-01-01","conditions":["Infertility"],"enrollment":60,"completionDate":"2015-01-01"},{"nctId":"NCT04375657","phase":"PHASE2","title":"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial","status":"RECRUITING","sponsor":"Intervene Immune, Inc.","startDate":"2020-11-23","conditions":["Epigenetic Aging","Immunosenescence"],"enrollment":85,"completionDate":"2025-12"},{"nctId":"NCT05692960","phase":"NA","title":"Women's Interventions for Sexual Health: WISH","status":"COMPLETED","sponsor":"The University of Tennessee, Knoxville","startDate":"2023-02-15","conditions":["Sexual Dysfunction, Physiological","Body Image","Libido; Loss, Aversion"],"enrollment":30,"completionDate":"2024-02-09"},{"nctId":"NCT04979377","phase":"","title":"Prevalence of Hyperandrogenism in Type 1 Diabetes","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2020-03-09","conditions":["Type 1 Diabetes","Polycystic Ovary Syndrome","Hyperandrogenism","Hirsutism","Oligomenorrhea","Ovulation Disorder"],"enrollment":150,"completionDate":"2024-12-30"},{"nctId":"NCT05586711","phase":"PHASE4","title":"Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women","status":"COMPLETED","sponsor":"Angelica Lindén Hirschberg","startDate":"2020-12-18","conditions":["Vulvovaginal Atrophy","Genitourinary Syndrome of Menopause"],"enrollment":170,"completionDate":"2024-12-15"},{"nctId":"NCT06729359","phase":"","title":"Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2024-07-01","conditions":["PCOS (Polycystic Ovary Syndrome)","Stone, Urinary","BMI","Obesity","Overweight","Underweight"],"enrollment":407,"completionDate":"2024-11-15"},{"nctId":"NCT05316272","phase":"NA","title":"Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-03-11","conditions":["Low Bone Density","Osteoporosis"],"enrollment":41,"completionDate":"2024-06-30"},{"nctId":"NCT03227458","phase":"NA","title":"DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-02-12","conditions":["Low Bone Mass","Osteoporosis, Postmenopausal"],"enrollment":152,"completionDate":"2024-06-19"},{"nctId":"NCT04493333","phase":"PHASE2","title":"Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2021-06-07","conditions":["Vaginal Atrophy","Postmenopausal Symptoms","Breast Cancer Female","Long-term Survivors"],"enrollment":8,"completionDate":"2023-07-18"},{"nctId":"NCT06611514","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"European Institute of Oncology","startDate":"2024-12-01","conditions":["Women With Breast Cancer"],"enrollment":95,"completionDate":"2027-01-01"},{"nctId":"NCT04982692","phase":"PHASE3","title":"A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-09-13","conditions":["Postmenopausal Vulvovaginal Atrophy"],"enrollment":417,"completionDate":"2023-05-08"},{"nctId":"NCT05471453","phase":"NA","title":"Effectiveness of Adjuvant Supplements Prior to in IVF","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2022-03-02","conditions":["Dietary Supplements"],"enrollment":70,"completionDate":"2023-12-31"},{"nctId":"NCT03383133","phase":"EARLY_PHASE1","title":"Studies of Sulfur Metabolism in Humans","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-01-11","conditions":["Metabolic Side Effects of Drugs"],"enrollment":1,"completionDate":"2023-02-02"},{"nctId":"NCT05434351","phase":"","title":"The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone","status":"TERMINATED","sponsor":"Chinese University of Hong Kong","startDate":"2022-08-01","conditions":["Genitourinary Syndrome of Menopause"],"enrollment":4,"completionDate":"2023-02-23"},{"nctId":"NCT05263557","phase":"NA","title":"Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)","status":"UNKNOWN","sponsor":"Royal College of Surgeons, Ireland","startDate":"2022-08-19","conditions":["Polycystic Ovary Syndrome","Insulin Resistance","Androgen; Hypersecretion","Endocrine System Diseases"],"enrollment":20,"completionDate":"2024-12"},{"nctId":"NCT02432248","phase":"NA","title":"Effect of DHEA on Patients With Poor Ovarian Responds","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Inner Mongolia Medical University","startDate":"2015-02","conditions":["Subfertility"],"enrollment":350,"completionDate":"2024-12"},{"nctId":"NCT05900661","phase":"PHASE2,PHASE3","title":"The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":["Poor Responders"],"enrollment":300,"completionDate":"2023-09-30"},{"nctId":"NCT05903716","phase":"","title":"The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris","status":"UNKNOWN","sponsor":"Marmara University","startDate":"2022-09-15","conditions":["Acne Vulgaris"],"enrollment":40,"completionDate":"2023-06-30"},{"nctId":"NCT05346159","phase":"","title":"Effects of Adrenal Androgens on Gender-typed Behavior in Girls With Turner Syndrome","status":"COMPLETED","sponsor":"Sohag University","startDate":"2022-05-01","conditions":["Turner Syndrome"],"enrollment":78,"completionDate":"2023-05-31"},{"nctId":"NCT05856604","phase":"NA","title":"Music Therapy for Older Adults With Cognitive Decline Living in Care Homes","status":"COMPLETED","sponsor":"Middlesex University","startDate":"2018-02-01","conditions":["Cognitive Impairment","Cognitive Decline"],"enrollment":42,"completionDate":"2019-08-28"},{"nctId":"NCT03491007","phase":"PHASE2","title":"Neurosteroids in PTSD - Biomarkers to Therapeutics","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-07-08","conditions":["Posttraumatic Stress Disorder"],"enrollment":5,"completionDate":"2020-11-16"},{"nctId":"NCT05811507","phase":"","title":"Evaluation of Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-04","conditions":["Autism Spectrum Disorder"],"enrollment":100,"completionDate":"2024-04"},{"nctId":"NCT05246865","phase":"NA","title":"Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"University of Birmingham","startDate":"2021-10-10","conditions":["Polycystic Ovary Syndrome"],"enrollment":100,"completionDate":"2025-05-30"},{"nctId":"NCT04066478","phase":"PHASE2,PHASE3","title":"Does DHEA IVF Outcomes in Poor Responders?","status":"SUSPENDED","sponsor":"Homerton University Hospital NHS Foundation Trust","startDate":"2017-10-08","conditions":["Infertility, Female","Poor Response to Ovulation Induction"],"enrollment":400,"completionDate":"2022-12-31"},{"nctId":"NCT03568604","phase":"PHASE4","title":"Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia","status":"COMPLETED","sponsor":"San Diego Sexual Medicine","startDate":"2018-08-07","conditions":["Dyspareunia"],"enrollment":18,"completionDate":"2020-01-28"},{"nctId":"NCT04833192","phase":"","title":"Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2020-04-01","conditions":["Adrenal Incidentaloma","Subclinical Hypercortisolism"],"enrollment":202,"completionDate":"2023-12-30"},{"nctId":"NCT04705883","phase":"PHASE4","title":"Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2020-09-01","conditions":["Vulvar Atrophy","Breast Cancer","Genitourinary Syndrome of Menopause"],"enrollment":10,"completionDate":"2021-12-01"},{"nctId":"NCT04517136","phase":"","title":"Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions","status":"UNKNOWN","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2020-09-14","conditions":["Covid19","SARS-CoV Infection","Burnout, Caregiver","Burnout, Professional"],"enrollment":39,"completionDate":"2022-03"},{"nctId":"NCT01273259","phase":"PHASE2","title":"Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2008-05-06","conditions":["Chronic Obstructive Pulmonary Disease","Hypertension, Pulmonary"],"enrollment":51,"completionDate":"2015-06-05"},{"nctId":"NCT03594968","phase":"","title":"Oxidative Stress in Polycystic Ovary Syndrome With Periodontal Disease and Dental Caries Lesions","status":"COMPLETED","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2018-04-15","conditions":["Polycystic Ovary Syndrome","Dental Caries"],"enrollment":206,"completionDate":"2019-05-15"},{"nctId":"NCT05033574","phase":"","title":"The State of Sexual Development in Children With Inherited Epidermolysis Bullosa","status":"UNKNOWN","sponsor":"National Medical Research Center for Children's Health, Russian Federation","startDate":"2020-12-08","conditions":["Dermatologic Disease","Epidermolysis Bullosa","Epidermolysis Bullosa Simplex","Epidermolysis Bullosa Dystrophica","Epidermolysis Bullosa, Junctional","Kindler Syndrome","Puberty Disorders","Hormone Disturbance"],"enrollment":50,"completionDate":"2023-06-01"},{"nctId":"NCT04988269","phase":"","title":"Assessment of Diurnal Salivary Cortisol Production in COVID-19","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2021-04-15","conditions":["COVID-19","Adrenal Insufficiency","Adrenal Hyperfunction"],"enrollment":85,"completionDate":"2021-07-28"},{"nctId":"NCT04960982","phase":"","title":"Changes in Pregnancy in Egyptian Women With History of Recurrent Miscarriage","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2018-03-01","conditions":["Polycystic Ovary Syndrome"],"enrollment":40,"completionDate":"2021-05-01"},{"nctId":"NCT03854396","phase":"PHASE3","title":"Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women","status":"WITHDRAWN","sponsor":"Olivia Cardenas-Trowers, M.D.","startDate":"2020-05","conditions":["Recurrent Urinary Tract Infection","Postmenopause","Postmenopausal Syndrome","Postmenopausal Symptoms","Menopause"],"enrollment":0,"completionDate":"2021-02"},{"nctId":"NCT04898556","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain","status":"UNKNOWN","sponsor":"Dr. Santiago Palacios","startDate":"2020-12-22","conditions":["Vulvovaginal Atrophy"],"enrollment":50,"completionDate":"2021-06-30"},{"nctId":"NCT04782024","phase":"PHASE2","title":"A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults","status":"COMPLETED","sponsor":"KGK Science Inc.","startDate":"2015-09-30","conditions":["Resting Metabolic Rate","Overweight Subjects"],"enrollment":138,"completionDate":"2016-11-04"},{"nctId":"NCT03287232","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2017-10-16","conditions":["Hypoactive Sexual Desire Disorder"],"enrollment":653,"completionDate":"2019-07-22"},{"nctId":"NCT04365335","phase":"","title":"Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2020-04-25","conditions":["Occupational Stress"],"enrollment":50,"completionDate":"2020-06-12"},{"nctId":"NCT03438812","phase":"NA","title":"Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2017-09-06","conditions":["Poor Responders","Dehydroepiandrosterone"],"enrollment":66,"completionDate":"2019-12-31"},{"nctId":"NCT01662466","phase":"PHASE1,PHASE2","title":"Effect of Testosterone Treatment on Embryo Quality","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2012-07-01","conditions":["Primary Ovarian Insufficiency","Female Infertility Due to Diminished Ovarian Reserve"],"enrollment":180,"completionDate":"2022-12-31"},{"nctId":"NCT03010891","phase":"NA","title":"Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes During Invasive Procedures","status":"COMPLETED","sponsor":"National Defense Medical Center, Taiwan","startDate":"2016-03","conditions":["Preterm Infants","Stress"],"enrollment":66,"completionDate":"2018-05"},{"nctId":"NCT04555018","phase":"","title":"Correlation Between Dehydroepiandrosterone Sulfate and Sebum Level in Adult Female Acne Vulgaris","status":"COMPLETED","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2017-06-01","conditions":["Acne Vulgaris","Female"],"enrollment":50,"completionDate":"2017-10-01"},{"nctId":"NCT03619005","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-13","conditions":["Hypoactive Sexual Desire Disorder (HSDD)"],"enrollment":0,"completionDate":"2019-12-06"},{"nctId":"NCT03740945","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-06","conditions":["Vaginal Atrophy in Breast Cancer Patients"],"enrollment":0,"completionDate":"2019-12-05"},{"nctId":"NCT04355663","phase":"NA","title":"Neuroproprioceptive \"Facilitation, Inhibition\" and Brain Plasticity","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":["Multiple Sclerosis"],"enrollment":92,"completionDate":"2019-08-01"},{"nctId":"NCT04379193","phase":"NA","title":"Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":["Multiple Sclerosis"],"enrollment":63,"completionDate":"2019-09-01"},{"nctId":"NCT04369248","phase":"","title":"Hepassocin Levels in Patients With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Fatma ketenci gencer","startDate":"2020-01-03","conditions":["Hepassocin (Hepatocyte-derived Fibrinogen-related Protein 1)","Polycystic Ovary Syndrome","Obesity","Insulin Resistance"],"enrollment":90,"completionDate":"2020-03-25"},{"nctId":"NCT03418363","phase":"PHASE4","title":"How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-01-16","conditions":["Contraceptive Usage","Coagulation"],"enrollment":15,"completionDate":"2019-12-11"},{"nctId":"NCT02866253","phase":"PHASE4","title":"Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2014-12","conditions":["Infertility"],"enrollment":78,"completionDate":"2016-02"},{"nctId":"NCT00972023","phase":"PHASE1","title":"DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2010-02","conditions":["Breast Cancer"],"enrollment":1,"completionDate":"2010-08-22"},{"nctId":"NCT00607646","phase":"EARLY_PHASE1","title":"Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-10","conditions":["Type 1 Diabetes"],"enrollment":50,"completionDate":"2018-10-09"},{"nctId":"NCT02683148","phase":"PHASE1","title":"DHEA in Synovial Sarcoma Patients","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2016-09-13","conditions":["Synovial Sarcoma","Sarcoma, Synovial"],"enrollment":11,"completionDate":"2019-04-04"},{"nctId":"NCT03967964","phase":"PHASE1","title":"Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2015-11-20","conditions":["Pharmacokinetics","Hormone Deficiency"],"enrollment":46,"completionDate":"2016-07-15"},{"nctId":"NCT02268032","phase":"PHASE1","title":"Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2014-07-15","conditions":["Healthy Women","Infertility, Female"],"enrollment":94,"completionDate":"2016-08-31"},{"nctId":"NCT01376349","phase":"PHASE3","title":"Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2011-07","conditions":["Breast Cancer","Gynecologic Cancer"],"enrollment":464,"completionDate":"2017-11"},{"nctId":"NCT03782480","phase":"PHASE3","title":"Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy","status":"UNKNOWN","sponsor":"Center for Vulvovaginal Disorders","startDate":"2019-03-02","conditions":["Menopause","Genitourinary Syndrome of Menopause","Vulvovaginal Atrophy","Menopause Syndrome","Dyspareunia"],"enrollment":40,"completionDate":"2021-01-02"},{"nctId":"NCT03783988","phase":"PHASE1","title":"Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids","status":"UNKNOWN","sponsor":"Trophea Development AB","startDate":"2019-01-15","conditions":["Skin Atrophy"],"enrollment":10,"completionDate":"2019-06"},{"nctId":"NCT01702818","phase":"","title":"Stress Hormones, Mood and Women's Sexual Desire (MODEST)","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2012-02","conditions":["Hypoactive Sexual Desire Disorder (HSDD)"],"enrollment":324,"completionDate":"2016-11"},{"nctId":"NCT03621683","phase":"NA","title":"Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve","status":"COMPLETED","sponsor":"Lucy Coleman","startDate":"2016-01-06","conditions":["Ovarian Reserve"],"enrollment":78,"completionDate":"2017-08-28"},{"nctId":"NCT01535872","phase":"PHASE3","title":"Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients","status":"COMPLETED","sponsor":"KK Women's and Children's Hospital","startDate":"2012-02","conditions":["Infertility","Poor Responder to IVF Treatment"],"enrollment":60,"completionDate":"2017-11"},{"nctId":"NCT00310791","phase":"PHASE2,PHASE3","title":"Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2004-04","conditions":["Anorexia Nervosa"],"enrollment":80,"completionDate":"2010-12"},{"nctId":"NCT02794948","phase":"PHASE1,PHASE2","title":"Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency","status":"COMPLETED","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2016-04","conditions":["Primary Ovarian Insufficiency"],"enrollment":48,"completionDate":"2017-12"},{"nctId":"NCT02766764","phase":"PHASE4","title":"Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":["Subfertility"],"enrollment":230,"completionDate":""},{"nctId":"NCT01724242","phase":"PHASE2,PHASE3","title":"Vaginal DHEA for Women After Breast Cancer","status":"WITHDRAWN","sponsor":"Hadassah Medical Organization","startDate":"2013-02","conditions":["Vaginal Dryness","Breast Cancer","Urinary Incontinence","Quality of Life","Sexual Satisfaction"],"enrollment":0,"completionDate":"2014-12"},{"nctId":"NCT01256671","phase":"PHASE3","title":"DHEA Against Vaginal Atrophy - Safety Study of 12 Months","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2010-12","conditions":["Vaginal Atrophy"],"enrollment":530,"completionDate":"2012-12"},{"nctId":"NCT01846442","phase":"PHASE3","title":"Topical DHEA Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2007-06","conditions":["Vaginal Atrophy"],"enrollment":218,"completionDate":"2008-10"},{"nctId":"NCT01256684","phase":"PHASE3","title":"DHEA Against Vaginal Atrophy - 3-Month Efficacy Study","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2010-12","conditions":["Vaginal Atrophy"],"enrollment":255,"completionDate":"2011-11"},{"nctId":"NCT01358760","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2011-06","conditions":["Vaginal Atrophy"],"enrollment":450,"completionDate":"2012-05"},{"nctId":"NCT02013544","phase":"PHASE3","title":"Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2014-02","conditions":["Vaginal Atrophy"],"enrollment":558,"completionDate":"2015-02"},{"nctId":"NCT02549690","phase":"NA","title":"Testosterone Gel in Poor Responders Undergoing IVF","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2015-09","conditions":["Infertility"],"enrollment":0,"completionDate":"2016-08"},{"nctId":"NCT00248989","phase":"PHASE3","title":"Effect of DHEA on Skin Aging in Postmenopausal Women","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2004-11-01","conditions":["Skin Aging","Quality of Life"],"enrollment":150,"completionDate":"2008-11-13"},{"nctId":"NCT00317148","phase":"PHASE2,PHASE3","title":"Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal Women","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2005-08","conditions":["Hot Flashes"],"enrollment":50,"completionDate":"2007-12"},{"nctId":"NCT00429806","phase":"PHASE1","title":"DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2006-11","conditions":["Vaginal Atrophy"],"enrollment":40,"completionDate":"2007-07"},{"nctId":"NCT02229604","phase":"PHASE1","title":"Electroacupuncture for Diminished Ovarian Reserve","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2014-01","conditions":["Irregular Menses"],"enrollment":57,"completionDate":"2016-09"},{"nctId":"NCT02000375","phase":"PHASE2","title":"A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-03","conditions":["Metastatic Breastcancer","Estrogen Receptor Positive Breast Cancer","Estrogen Receptor Negative Neoplasm","Progesterone Receptor Positive Tumor","Progesterone Receptor Negative Neoplasm","Androgen Receptor Gene Overexpression"],"enrollment":20,"completionDate":"2016-02"},{"nctId":"NCT00516698","phase":"","title":"Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2007-09","conditions":["Breast Cancer"],"enrollment":140,"completionDate":"2009-12"},{"nctId":"NCT02736591","phase":"PHASE3","title":"Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":["Subfertility"],"enrollment":210,"completionDate":""},{"nctId":"NCT02561793","phase":"PHASE3","title":"DHEA Versus Placebo in Women With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-10","conditions":["Subfertility"],"enrollment":440,"completionDate":"2017-09"},{"nctId":"NCT00189124","phase":"PHASE2,PHASE3","title":"Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2003-09","conditions":["Systemic Lupus Erythematosus"],"enrollment":13,"completionDate":"2006-07"},{"nctId":"NCT00005246","phase":"","title":"Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1989-08","conditions":["Cardiovascular Diseases","Heart Diseases","Coronary Disease"],"enrollment":0,"completionDate":"1991-07"},{"nctId":"NCT00289926","phase":"PHASE3","title":"Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms","status":"COMPLETED","sponsor":"Monash University","startDate":"2006-02","conditions":["Quality of Life","Menopausal Syndrome","Libido Disorder"],"enrollment":240,"completionDate":"2008-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"2334LJD2E9","SPL_ID":"8c95390f-f204-41d4-a7c8-22a37a5a04ef","chemblId":"CHEMBL1875999"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Pro Weight Loss Inc.","relationship":"Original Developer"}],"publicationCount":8218,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Pro Weight Loss Inc.","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Pro Weight Loss Inc.","companyId":"pro-weight-loss-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":6,"withResults":1},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:03:53.866543+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}